Fundamental analysis

DGAP-News: Nemetschek SE continues its highly profitable growth course in Q2 and increases its forecast for the fiscal year 2021

Retrieved on: 
星期四, 七月 29, 2021

We were consequently able to continue with our strong and highly profitable growth in the second quarter.

Key Points: 
  • We were consequently able to continue with our strong and highly profitable growth in the second quarter.
  • - In Q2, Group revenue rose by 17.2% (currency-adjusted: 21.5%) to EUR 165.9 million (Q2 2020: EUR 141.6 million).
  • As a result of the high growth and increased efficiency, the EBITDA margin expanded considerably to 34.0% (Q2 2020: 28.8%).
  • The currency-adjusted revenue growth is now expected to be in a range between 12% and 14% (previously: at least high single-digit percentage growth).

Factor Launches 'Factor Connect' Partnership Program to Accelerate Innovation

Retrieved on: 
星期三, 七月 28, 2021

NEW YORK, July 28, 2021 /PRNewswire-PRWeb/ -- In another step toward broader collaboration with the global legal ecosystem, New Law pioneer Factor today announced its inaugural partnership program, Factor Connect , bringing together world-class legal technology providers and specialists to help accelerate innovation in the delivery of legal services.

Key Points: 
  • NEW YORK, July 28, 2021 /PRNewswire-PRWeb/ -- In another step toward broader collaboration with the global legal ecosystem, New Law pioneer Factor today announced its inaugural partnership program, Factor Connect , bringing together world-class legal technology providers and specialists to help accelerate innovation in the delivery of legal services.
  • Factor's partner program launches today with an initial cohort of five participating companies, whose tools Factor has thoroughly tested and validated both internally and among clients for effectiveness and fit with Factor's methodologies.
  • Factor will work with:
    Acadia , offering digitization and regulatory compliance services for financial services documentation with secure and scalable methods.
  • "Coming together today is just the beginning announcing our partnership program is also an open invitation to the market to come and work with us."

BIOREM Reports Second Quarter 2021 Financial Results

Retrieved on: 
星期三, 七月 28, 2021

Biorem's revenues for the second quarter were $5.6 million a 64% increase over the previous quarter and on par with the $5.9 million of revenues reported in the same quarter in 2020.

Key Points: 
  • Biorem's revenues for the second quarter were $5.6 million a 64% increase over the previous quarter and on par with the $5.9 million of revenues reported in the same quarter in 2020.
  • Gross profit for the quarter was $1.1 million or 20.0% of revenue compared to $1.4 million of gross profit representing 23.9 % of revenue recorded during the second quarter of 2020.
  • Ebitda for the quarter was $467,000 compared to $504,000 of ebitda in the second quarter of 2020.
  • "Second quarter results were a rebound from Q1 but project delays continued to hamper financial results", said Derek S. Webb, President and CEO.

Mastech Digital Reports Healthy Second Quarter 2021 Results

Retrieved on: 
星期三, 七月 28, 2021

PITTSBURGH, July 28, 2021 /PRNewswire/ -- Mastech Digital, Inc. (NYSE American: MHH), a leading provider of Digital Transformation IT Services, announced today its financial results for the second quarter ended June 30, 2021.

Key Points: 
  • PITTSBURGH, July 28, 2021 /PRNewswire/ -- Mastech Digital, Inc. (NYSE American: MHH), a leading provider of Digital Transformation IT Services, announced today its financial results for the second quarter ended June 30, 2021.
  • Consolidated revenues totaled $53.7 million, a 13% increase over the second quarter 2020, with sequential growth of 8% compared to the first quarter of 2021;
    The Company's Data and Analytics Services segment reported its second consecutive quarter of strong bookings as client demand increased in the second quarter of 2021;
    The IT Staffing Services segment added an additional 89 consultants-on-billing, an increase of 8% during the quarter, as demand for its services remained strong;
    Consolidated gross margins increased slightly during the quarter on a year-over-year basis and were 100 basis points higher than in the first quarter of 2021;
    GAAP diluted earnings per share were $0.31 in the second quarter of 2021 versus $0.25 in the second quarter of 2020; the second quarter of 2021 included a $2.0 million pre-tax gain related to a reduction in a contingent consideration liability;
    Non-GAAP diluted earnings per share were $0.29 in the second quarter of 2021 versus $0.33 in the second quarter of 2020, and represented an improvement of $0.10 over the first quarter of 2021.
  • Revenues for the second quarter of 2021 totaled $53.7 million, compared to $47.6 million during the corresponding quarter last year.Gross profits in the second quarter of 2021 were $14.3 million, compared to $12.7 million in the second quarter of 2020.
  • Non-GAAP net income for the second quarter of 2021 was $3.4 million or $0.29 per diluted share, compared to $3.9 million or $0.33 per diluted share in the second quarter of 2020.

Humana Reports Second Quarter 2021 Financial Results; Maintains Full Year 2021 Adjusted EPS Financial Guidance

Retrieved on: 
星期三, 七月 28, 2021

Accordingly, the company believes it is useful to adjust GAAP EPS for the market gains and losses of publicly-traded equity securities.

Key Points: 
  • Accordingly, the company believes it is useful to adjust GAAP EPS for the market gains and losses of publicly-traded equity securities.
  • Put/call valuation adjustments of approximately $227 million, or $1.32 per diluted common share, associated with Humanas non-consolidating minority interest investments.
  • (f) FY 2021 Adjusted EPS projections exclude the following:
    Amortization expense for identifiable intangibles of $0.39 per diluted common share.
  • FY 2021 GAAP EPS guidance excludes the impact of future value changes of these put/call options as the future value changes cannot be estimated.

Aware Reports Second Quarter 2021 Financial Results

Retrieved on: 
星期二, 七月 27, 2021

BEDFORD, Mass., July 27, 2021 (GLOBE NEWSWIRE) -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics software products, solutions and services, today reported financial results for the second quarter ended June 30, 2021.

Key Points: 
  • BEDFORD, Mass., July 27, 2021 (GLOBE NEWSWIRE) -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics software products, solutions and services, today reported financial results for the second quarter ended June 30, 2021.
  • Revenue for the second quarter of 2021 was $4.3 million, compared to $4.4 million in the first quarter of 2021 and up 2.3 times from $1.9 million in the same year-ago period.
  • Adjusted EBITDA loss (a non-GAAP metric reconciled below) for the second quarter of 2021 was $0.9 million, compared to adjusted EBITDA loss of $3.3 million in the same year-ago period.
  • Aware wishes to caution you that there are factors that could cause actual results to differ materially from the results indicated by such statements.

Capstone Generated Record Operating Cash Flow of $110 Million in Q2 2021; Net Cash Grows to $172 Million With Zero Drawn Long-Term Debt

Retrieved on: 
星期二, 七月 27, 2021

Extensive column leach test work in collaboration with Jetti Resources LLC (Jetti) has commenced and will continue through early 2022.

Key Points: 
  • Extensive column leach test work in collaboration with Jetti Resources LLC (Jetti) has commenced and will continue through early 2022.
  • Current capital estimate of approximately $90 million includes additional regrind milling capacity and this will be further refined as part of the PV4 study.
  • Accordingly, these Non-GAAP financial measures may provide insight to investors and other external users of the Company's consolidated financial information.
  • EBITDA is net income (loss) attributable to shareholders before net finance expense, tax expense, and depletion and amortization.

2Q21 Results: Telefônica Brasil S.A.

Retrieved on: 
星期二, 七月 27, 2021

Fiber-to-the-homebroadband customers totaled 4 million (+41.3% y-o-y), posting strong net additions in 2Q21.

Key Points: 
  • Fiber-to-the-homebroadband customers totaled 4 million (+41.3% y-o-y), posting strong net additions in 2Q21.
  • Recurring EBITDA totaled R$4,226 million (+3.0% y-o-y) in 2Q21, with a recurring EBITDA margin of 39.7%.
  • Investmentsof R$2,251 million in 2Q21, focused on the expansion of the FTTH network and the capacity of the 4G and 4.5G networks.
  • Free Cash Flow after Leasing paymentstotaled R$1,868 million in 2Q21, reflecting the ongoing, efficient Company's financial management.

Total Play Announces 97% Increase In EBITDA, To Ps. 2,957 Million In The Second Quarter Of 2021

Retrieved on: 
星期二, 七月 27, 2021

Given the notable demand for Total Play services, the company makes investments to increase geographic coverage and further expand its subscriber base.

Key Points: 
  • Given the notable demand for Total Play services, the company makes investments to increase geographic coverage and further expand its subscriber base.
  • The company recorded operating income of Ps.884 million, versus an operating loss of Ps.44 million in the second quarter of 2020.
  • Total Play reported net income of Ps.560 million, from a loss of Ps.339 million in the same period of 2020.
  • Total Play reported EBITDA of Ps.5,633 million, 79% above the Ps.3,141 million of the previous year.

H.I.G. Capital Announces the Sale of US MED

Retrieved on: 
星期二, 七月 27, 2021

"), a leading global alternative investment firm with $45 billion of equity capital under management, announced today the sale of its portfolio company, US Medical Supply (US MED or the Company), to Advanced Diabetes Supply (ADS), a portfolio company of Court Square Capital Partners Inc.

Key Points: 
  • "), a leading global alternative investment firm with $45 billion of equity capital under management, announced today the sale of its portfolio company, US Medical Supply (US MED or the Company), to Advanced Diabetes Supply (ADS), a portfolio company of Court Square Capital Partners Inc.
  • Additionally, US MED implemented a robust, institutionalized compliance program and invested meaningfully in technology and automation.
  • US MED grew revenue and EBITDA nearly three-fold during H.I.G.s ownership, generating an outstanding return to H.I.G.
  • Capital, commented, It has been a distinct pleasure working with Bill and his team to complete the strategic transformation of US MED.